International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Elsevier
2018
|
| _version_ | 1797092402384601088 |
|---|---|
| author | Williamson, K Lytvyak, E De Krijger, M Trivedi, P Estes, D Yu, L Pratt, D De Vries, A Daretti, L Liu, C Bowlus, C Marschall, H Montano-Loza, A Chapman, R Van Der Woude, C Marzioni, M Keshav, S Ponsioen, C Hirschfield, G Levy, C |
| author_facet | Williamson, K Lytvyak, E De Krijger, M Trivedi, P Estes, D Yu, L Pratt, D De Vries, A Daretti, L Liu, C Bowlus, C Marschall, H Montano-Loza, A Chapman, R Van Der Woude, C Marzioni, M Keshav, S Ponsioen, C Hirschfield, G Levy, C |
| author_sort | Williamson, K |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T03:45:29Z |
| format | Conference item |
| id | oxford-uuid:bf535b91-e517-46f5-a00b-dd2796ae0096 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T03:45:29Z |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:bf535b91-e517-46f5-a00b-dd2796ae00962022-03-27T05:46:38ZInternational experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel diseaseConference itemhttp://purl.org/coar/resource_type/c_5794uuid:bf535b91-e517-46f5-a00b-dd2796ae0096Symplectic Elements at OxfordElsevier2018Williamson, KLytvyak, EDe Krijger, MTrivedi, PEstes, DYu, LPratt, DDe Vries, ADaretti, LLiu, CBowlus, CMarschall, HMontano-Loza, AChapman, RVan Der Woude, CMarzioni, MKeshav, SPonsioen, CHirschfield, GLevy, C |
| spellingShingle | Williamson, K Lytvyak, E De Krijger, M Trivedi, P Estes, D Yu, L Pratt, D De Vries, A Daretti, L Liu, C Bowlus, C Marschall, H Montano-Loza, A Chapman, R Van Der Woude, C Marzioni, M Keshav, S Ponsioen, C Hirschfield, G Levy, C International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease |
| title | International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease |
| title_full | International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease |
| title_fullStr | International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease |
| title_full_unstemmed | International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease |
| title_short | International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease |
| title_sort | international experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease |
| work_keys_str_mv | AT williamsonk internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT lytvyake internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT dekrijgerm internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT trivedip internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT estesd internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT yul internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT prattd internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT devriesa internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT darettil internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT liuc internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT bowlusc internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT marschallh internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT montanolozaa internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT chapmanr internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT vanderwoudec internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT marzionim internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT keshavs internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT ponsioenc internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT hirschfieldg internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease AT levyc internationalexperienceofvedolizumabinprimarysclerosingcholangitisandinflammatoryboweldisease |